Magdalena M.
- Country
- Romania
- Department
- N/A
Research Overview
- Effect of Muvalaplin on Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) and Atherosclerotic Cardiovascular Disease: A Phase 3 Randomized Trial
- Evaluation of Retatrutide (LY3437943) Efficacy and Safety in Obesity, Overweight, and Knee Osteoarthritis: A Randomized, Double-Blind, Placebo-Controlled Trial
- Evaluation of Semaglutide in Patients with Non-Cirrhotic Non-Alcoholic Steatohepatitis and Fibrosis Stages 2 or 3: A Randomized, Placebo-Controlled Trial
Data & Insights
Has run more than one trial at 358 of 1036 partner sites.
Specializations
Metabolic Disorders
The investigator specializes in treating complex metabolic conditions, with particular emphasis on Type 2 Diabetes Mellitus and its management through innovative therapeutic approaches.
- Glycemic Control Optimization
- Insulin Management Strategies
- Novel Diabetes Therapeutics
Their research extends to investigating new oral and injectable treatments for diabetes management.
Weight Management
The investigator focuses on treating obesity and weight-related conditions, particularly in patients with concurrent metabolic disorders.
- Obesity Treatment
- Weight Management in Diabetes
- Cardiovascular Risk Management
Their expertise includes comprehensive approaches to weight management in high-risk populations.
Hepatic and Cardiovascular Health
The investigator has significant experience in treating Non-alcoholic Steatohepatitis (NASH) and related cardiovascular conditions.
- Liver Disease Management
- Cardiovascular Risk Reduction
- Lipid Disorders Treatment
Their work includes investigating treatments for severe hypertriglyceridemia and liver-related conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.